The New Radiolabeled Peptide <sup>99m</sup>TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
(1) Background: The aim of our study is to reveal the advantages and limitations of the use of <sup>99m</sup>TcEDDA/HYNIC-TOC (Tektrotyd<sup>®</sup>, Polatom) in the diagnosis of gastroenteropancreatic neuroendocrine tumors and to compare our results with the values obtained...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/11/2725 |